A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

…, T Moran, R Karaliuskas, RH Duerr, JP Achkar… - Nature, 2001 - nature.com
Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract, which is
thought to result from the effect of environmental factors in a genetically predisposed host. A …

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

…, P Goyette, Z Wei, C Abraham, JP Achkar… - Nature, 2012 - nature.com
Crohn’s disease and ulcerative colitis, the two common forms of inflammatory bowel disease
(IBD), affect over 2.5 million people of European ancestry, with rising prevalence in other …

Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study

…, DPB McGovern, J Wu, V Annese, JP Achkar… - Nature …, 2009 - nature.com
Ulcerative colitis is a chronic inflammatory disease of the colon that presents as diarrhea
and gastrointestinal bleeding. We performed a genome-wide association study using DNA …

ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis

CR Homer, AL Richmond, NA Rebert, JP Achkar… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: The identification of numerous genes that confer susceptibility to
Crohn's disease (CD) indicates that this complex disease might arise from alterations in …

Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis

…, JH Cho, PK Gregersen, Y Wu, JP Achkar… - Human molecular …, 2004 - academic.oup.com
Nuclear Factor-κB (NF-κB) is a major transcription regulator of immune response, apoptosis
and cell-growth control genes, and is upregulated in inflammatory bowel disease (IBD), both …

An evidence-based systematic review on medical therapies for inflammatory bowel disease

NJ Talley, MT Abreu, JP Achkar… - Official journal of the …, 2011 - journals.lww.com
S3 Evidence-Based Systematic Review on Medical Therapies for IBD also has a high
incidence in New Zealand, suggesting that the disease may get more common the further the …

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

…, L Padyukov, S Brand, M Sans, V Annese, JP Achkar… - Nature …, 2013 - nature.com
Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to
fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation 1 , 2 , …

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis

B Shen, JP Achkar, BA Lashner… - Inflammatory bowel …, 2001 - academic.oup.com
Metronidazole is effective for the treatment of acute pouchitis after ileal pouch–anal anastomosis,
but it has not been directly compared with other antibiotics. This randomized clinical …

Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis

AC Ford, JP Achkar, KJ Khan, SV Kane… - Official journal of the …, 2011 - journals.lww.com
OBJECTIVES: The efficacy of 5-aminosalicylic acids (5-ASAs) in ulcerative colitis (UC) has
been studied previously in meta-analyses. However, several randomized controlled trials (…

Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis

B Shen, JP Achkar, JT Connor… - Diseases of the colon …, 2003 - journals.lww.com
PURPOSE: Pouchitis is the most common complication of ileal pouch-anal anastomosis for
ulcerative colitis. Our previous study suggested that symptoms alone are not reliable for the …